Barinthus Biotherapeutics (BRNS) EBITDA Margin (QoQ) (2020 - 2023)
Barinthus Biotherapeutics (BRNS) EBITDA Margin (QoQ) (2020 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - |
| 10 | Barinthus Biotherapeutics | 25.29 Mn | 25.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -329,473.00 |
| Mar 31, 2023 | -420,198.00 |
| Dec 31, 2022 | -50,599.00 |
| Sep 30, 2022 | 3,981.00 |
| Jun 30, 2022 | 7,321.00 |
| Mar 31, 2022 | -166.68 Mn |
| Dec 31, 2021 | 169.59 Mn |
| Sep 30, 2021 | 1.90 Mn |
| Jun 30, 2021 | -4.53 Mn |
| Mar 31, 2021 | -14,951.00 |
| Dec 31, 2020 | -267,726.00 |
| Sep 30, 2020 | 80,461.00 |
| Jun 30, 2020 | -18,910.00 |